Stock Events

Stock Events

SIGA Technologies 

$3.26
286
+$0.02+0.62% 08:00 Today

Statistics

Day High
3.28
Day Low
3.11
52W High
9.45
52W Low
2.83
Volume
1,076,942
Avg. Volume
678,849
Mkt Cap
232.79M
P/E Ratio
12.82
Dividend Yield
18.52%
Dividend
0.6

Upcoming

Dividends

18.52%Dividend Yield
Apr 26
$0.60
May 25
$0.60
Apr 24
$0.60
Jun 23
$0.45
Jun 22
$0.45
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
10.06%
1Y Growth
N/A

Earnings

5NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-0.09
0.15
0.39
0.63
Expected EPS
N/A
Actual EPS
N/A

Financials

24.61%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
94.58MRevenue
23.28MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SIGA. It's not an investment recommendation.
Microsoft
32
MSFT
Realty Income
32
O
Apple
31
AAPL
NVIDIA
30
NVDA

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Gilead Sciences
GILD
Mkt Cap180.64B
Gilead Sciences is a major player in the antiviral drug market, offering a range of products that compete with SIGA's portfolio.
Biomarin Pharmaceutical
BMRN
Mkt Cap12.52B
BioMarin Pharmaceutical develops and commercializes innovative biopharmaceuticals, potentially competing in the same therapeutic areas as SIGA.
Pfizer
PFE
Mkt Cap159.36B
Pfizer Inc, with its broad range of vaccines and antiviral drugs, competes in the same market as SIGA Technologies.
Moderna
MRNA
Mkt Cap55.09B
Moderna Inc is known for its mRNA technology used in vaccines, which could compete with SIGA's treatments in the infectious disease space.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson, through its pharmaceutical division, develops treatments that could compete with SIGA's antiviral and vaccine products.
Novavax
NVAX
Mkt Cap1.53B
Novavax, Inc. focuses on developing vaccines, including for viral infections, which places it in direct competition with SIGA.
Arbutus Biopharma
ABUS
Mkt Cap1B
Arbutus Biopharma Corporation works on antiviral therapies and delivery technologies, competing with SIGA in the antiviral space.
Inovio Pharmaceuticals
INO
Mkt Cap133.38M
Inovio Pharmaceuticals, Inc. specializes in DNA medicines, including vaccines for infectious diseases, competing with SIGA's offerings.
Vir Biotechnology
VIR
Mkt Cap1.83B
Vir Biotechnology, Inc. focuses on treating and preventing serious infectious diseases, directly competing with SIGA Technologies in the antiviral market.

About

SIGA Technologies Inc a commercial-stage pharmaceutical company. The Company sells its product, TPOX oral TPOXX, also known as tecovirimat, Tecovirimat-SIGA, or TEPOXX (tecovirimat) in certain international markets, to the U.S. Government and international governments (including government-affiliated entities). The Company operates in one single operating and reportable segment, which includes all activities related to the sale of the Company's Oral and IV TPOXX as well as research and development services.
Show more...
CEO
Diem Nguyen
Employees
49
Country
United States
ISIN
US8269171067

Listings

XNAS
US
SIGA
BOATS
BOATS
SIGA.BOATS

0 Comments

Share your thoughts

FAQ

What is SIGA Technologies stock price today?▼
The current price of SIGA is $3.26 USD — it has increased by +0.62% in the past 24 hours. Watch SIGA Technologies stock price performance more closely on the chart.
What is SIGA Technologies stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange SIGA Technologies stocks are traded under the ticker SIGA.
Is SIGA Technologies stock price growing?▼
SIGA stock has risen by +5.54% compared to the previous week, the month change is a -0.92% fall, over the last year SIGA Technologies has showed a -62.46% decrease.
What is SIGA Technologies market cap?▼
Today SIGA Technologies has the market capitalization of 232.79M
When is the next SIGA Technologies earnings date?▼
SIGA Technologies is going to release the next earnings report on November 05, 2026.
What were SIGA Technologies earnings last quarter?▼
SIGA earnings for the last quarter are 0.17 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is SIGA Technologies revenue for the last year?▼
SIGA Technologies revenue for the last year amounts to 94.58M USD.
What is SIGA Technologies net income for the last year?▼
SIGA net income for the last year is 23.28M USD.
Does SIGA Technologies pay dividends?▼
Yes, SIGA dividends are paid annual. The last dividend per share was 0.6 USD. As of today, Dividend Yield (FWD)% is 18.52%.
How many employees does SIGA Technologies have?▼
As of September 02, 2026, the company has 49 employees.
In which sector is SIGA Technologies located?▼
SIGA Technologies operates in the Health & Wellness sector.
When did SIGA Technologies complete a stock split?▼
SIGA Technologies has not had any recent stock splits.
Where is SIGA Technologies headquartered?▼
SIGA Technologies is headquartered in NEW YORK, United States.